Argent Mid Cap ETF (NASDAQ:AMID), Quote.Headers.trade-ideas

American Midstream Partners LP Com Units Repstg Ltd Partner Int

Technology

Industrials

Consumer Cyclical

Financial Services

Healthcare

Real Estate

Energy

Under normal circumstances, the Sub-Adviser expects the Fund will invest at least 80 percent of its net assets plus any borrowings for investment purposes in mid-capitalization companies. The Fund will generally hold 35 to 50 stocks of mid-capitalization companies that have a daily trading volume of at least dollar 20 million. While it is anticipated that the Fund will invest across a range of industries, certain sectors may be overweight compared to others because the Sub-Adviser seeks the best investment opportunities regardless of sector. The sectors in which the Fund may be overweight will vary at different points in the economic cycle. 

Fair Isaac Corp

Cdw Corp.

Copart Inc

Cintas Corp.

Medpace Holdings Inc

D R Horton Inc

Topbuild Corp

Builders Firstsource Inc

Cbiz Inc. 

Murphy Usa Inc

Argent Mid Cap ETF

builders first source

Equities

Large Cap

News

Management

Movers

AMID

BLDR

SMCF

Builders FirstSource, Inc. appoints Peter Jackson as President and CEO, effective November 6, 2024. Current CFO Pete Beckmann will become CFO. CEO Dave Rush will retire after 25 years and remain on board as special advisor. 

Builders FirstSource Taps CFO Peter Jackson For Top Role As CEO Dave Rush Plans Retirement

chart ai

Earnings

CSMD

CDW Corp shares down after reporting lower Q1 2024 results and missing expectations. CFO remains optimistic about future growth.

CDW&#39;s Challenging Quarter: Missed Sales Targets, Decline Across Key Segments

Movers & Shakers

Pre-Market Outlook

Markets

Trading Ideas

General

ACRS

ADIL

ADMP

AKTX

APPS

ARPO

ATOS

AVID

AVRO

AZRX

BIOS

CHAP

CHFS

CLRB

CODA

CWBR

DARE

DERM

DZSI

GLBS

GRTS

HEAR

ICON

INNT

KALV

KPTI

MESO

NIHD

OGEN

PHAS

PHII

QFIN

REPL

RMED

RMTI

SELB

SRNE

SRTS

SXTC

SYNA

TBIO

THOR

TPHS

VIOT

VTVT

60 Biggest Movers From Yesterday

Builders FirstSource, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>) shares are trading higher on Thursday. The company appointed Peter Jackson as its next President and CEO and <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/b40935211/builders-firstsource-announces-planned-ceo-and-cfo-transition" rel="noreferrer noopener">Pete Beckmann As CFO, effective November 6, 2024.</a>
Jackson, who is the current CFO, will succeed current CEO Dave Rush, who is retiring after 25 years of service.
Rush will remain on the Board of Directors and serve as a special advisor to ensure a smooth transition.
On the other hand, Pete Beckmann, currently Senior Vice President of Financial Planning &amp; Analysis at Builders FirstSource, will succeed Peter Jackson as CFO.
Beckmann, who has been with Builders FirstSource and its predecessor companies since 1999, has held various finance roles, including leading reporting, forecasting, strategic planning, and capital investment analysis.
Paul Levy, Chair of the Board of Directors, said, &#8220;Peter&#8217;s appointment as the Company&#8217;s next CEO underscores the Board&#8217;s steadfast commitment to excellence in our leadership team, and is the result of a thoughtful succession planning process.&#8221;
&#8220;Peter is a dynamic and innovative leader who has had wide-ranging impact on Builders FirstSource. He brings a strategic, operational, and finance-oriented mindset to his new role, as well as a deep understanding of our history, mission and strategy.&#8221;
Last month, the company&nbsp;reported second-quarter adjusted earnings per share of $3.50,&nbsp;beating the street view of $3.02, and sales of $4.456 billion <a target="_blank" href="https://www.benzinga.com/news/earnings/24/08/40197700/builders-firstsource-q2-eps-beat-lower-sales-and-1b-stock-buyback-more" rel="noreferrer noopener">missed&nbsp;the street view of $4.483 billion</a>.
As of June-end, liquidity was approximately $1.7 billion, consisting of $1.6 billion in net borrowing availability under the revolving credit facility and $0.1 billion cash on hand.
Investors can gain exposure to the stock via&nbsp;Themes US Small Cap Cash Flow Champions ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCF#NASDAQ">SMCF</a>) and Argent Mid Cap ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMID#NASDAQ">AMID</a>).
Price Action: BLDR shares are up 3.09% at $200.53 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40882613/builders-first-source-other-homebuilder-stocks-rise-with-catalysts-such-as-mortgage" target="_blank" rel="noreferrer noopener">Builders First Source, Other Homebuilder Stocks Rise With Catalysts Such As Mortgage Rates, The Fed, Kamala Harris Plan</a></li>
</ul>

CDW Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDW#NASDAQ">CDW</a>) shares are trading lower after the company reported worse-than-expected fiscal <a href="https://www.benzinga.com/pressreleases/24/05/b38545343/cdw-reports-first-quarter-2024-earnings" target="_blank" rel="noreferrer noopener">first-quarter 2024 results</a>.
Net sales declined 4.5% Y/Y to $4.87 billion, missing the consensus of $5.00 billion.&nbsp;
Adjusted EPS of $1.92 missed the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $2.15</a>.&nbsp;
Net sales from the Total Corporate segment declined 3.1%&nbsp;Y/Y&nbsp;to $2.14 billion, and the Total Small Business segment decreased 7.4%&nbsp;Y/Y&nbsp;to $381 million.
Total Public segment net sales fell 4.9%&nbsp;Y/Y&nbsp;to $1.73 billion due to a decline in net sales to Education customers&nbsp;by 10.4% Y/Y.
Net sales for&nbsp;CDW's&nbsp;U.K. and Canadian operations, combined as&nbsp;"Other"&nbsp;for financial reporting purposes, fell 6.5%&nbsp;Y/Y&nbsp;to $631 million.
Average daily sales fell 4.5% Y/Y to $76.1 million.&nbsp;Gross margin expanded to 21.8% from 21.3% a year ago, aided by a more favorable contribution of netted-down revenue, primarily software as a service.
The adjusted operating margin was 8.3% vs. 8.5% a year ago.&nbsp;
CDW held $803.8 million in cash and equivalents as of March 31, 2024.
Dividend: CDW declared a quarterly cash dividend per share of 62 cents.
&#8220;First quarter IT market conditions were weaker than expected, with caution, concern, and complexity adversely impacting customers&#8217; capital investment decisions and elongating customer decision-making. The resulting decline in solutions spend was partially offset by demand for client devices,&#8221; CFO Albert J. Miralles said. &#8220;We remain well-positioned to attain our target of exceeding US IT market growth by 200 to 300 basis points on a constant currency basis.&#8221;
CDW&nbsp;stock gained 42% in the last 12 months. Investors can gain exposure to the stock via&nbsp;Argent Mid Cap ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMID#NASDAQ">AMID</a>) and&nbsp;Professionally Managed Portfolios Congress SMid Growth ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSMD#NYSE">CSMD</a>).
Price Action: CDW shares are down 10.2% at $217.24 at last check Wednesday.
Now Read: <a href="https://www.benzinga.com/news/earnings/24/05/38555665/mastercard-says-consumer-spending-is-healthy-clocks-10-revenue-growth-in-q1">Mastercard Says Consumer Spending Is Healthy, Clocks 10% Revenue Growth In Q1</a>
Image generated using artificial intelligence via Midjourney.

CDW's Challenging Quarter: Missed Sales Targets, Decline Across Key Segments

American Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amid#NYSE">AMID</a>) today announced that it has notified the New York Stock Exchange ("NYSE") of the anticipated closing date of the previously-announced merger transactions contemplated by that certain Agreement and Plan of Merger, dated March 17, 2019, by and among the Partnership, American Midstream GP, LLC and affiliates of ArcLight Energy Partners Fund V, L.P. (the "Purchaser"). The Partnership anticipates that the merger will close on July 23, 2019.
Upon the closing of the merger on the terms and conditions set forth in the merger agreement, the Partnership will be a wholly owned subsidiary of the Purchaser. Following completion of the merger, the common units of the Partnership will cease to be listed on the NYSE and will be deregistered under the Securities Exchange Act of 1934.
About American Midstream Partners, LP

American Midstream Announces July 23, 2019 as Anticipated Closing Date of Merger with ArcLight Affiliate

American Midstream (NYSE:<a class="ticker" href="/stock/AMID#NYSE">AMID</a>) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.26) by 46.15 percent. This is a 9.52 percent increase over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $172.83 million which missed the analyst consensus estimate of $176.96 million by 2.33 percent. This is a 16.03 percent decrease over sales of $205.829 million the same period last year.

American Midstream Q1 EPS $(0.38) Misses $(0.26) Estimate, Sales $172.83M Miss $176.96M Estimate

American Midstream Announces Departure of President and Chief Executive Officer

American Midstream (NYSE:<a class="ticker" href="/stock/AMID#NYSE">AMID</a>) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.26) by 57.69 percent. This is a 24.07 percent increase over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $176.962 million which missed the analyst consensus estimate of $197.79 million by 10.53 percent. This is a 5.60 percent increase over sales of $167.582 million the same period last year.

American Midstream Q4 EPS $(0.41) Misses $(0.26) Estimate, Sales $176.962M Miss $197.79M Estimate

<h3>Gainers</h3>
<ul>
<li>Dare Bioscience Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dare#NASDAQ">DARE</a>) shares climbed 131.11 percent to close at $2.10 on Monday after the company published positive clinical findings for Tamoxifen for the treatment of vulvar and vaginal atrophy in a medical journal.</li>
<li>Dermira, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/derm#NASDAQ">DERM</a>) shares gained 82.16 percent to close at $12.61 after the company announced that its Phase 2 study of Lebrikizumab met its primary endpoint.</li>
<li>PhaseBio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phas#NASDAQ">PHAS</a>) gained 64.52 percent to close at $6.23 after the New England Journal of Medicine published the positive Phase 1 results for the company&#39;s PB2452.</li>
<li>Selecta Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/selb#NASDAQ">SELB</a>) shares rose 46.54 percent to close at $3.06.</li>
<li>Gritstone Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grts#NASDAQ">GRTS</a>) shares gained 31.43 percent to close at $13.34.</li>
<li>American Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amid#NYSE">AMID</a>) climbed 28.5 percent to close at $5.14 after the company announced that it would be acquired by ArcLight Energy for $5.25 per share.</li>
<li>Atossa Genetics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atos#NASDAQ">ATOS</a>) rose 24.47 percent to close at $4.40 after the company reported the receipt of $10 million from exercises of previously outstanding warrants.</li>
<li>Iconix Brand Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icon#NASDAQ">ICON</a>) gained 23.76 percent to close at $2.45.</li>
<li>Aclaris Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acrs#NASDAQ">ACRS</a>) gained 19.63 percent to close at $6.78 after the company reported higher-than-expected Q4 sales.</li>
<li>Rockwell Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rmti#NASDAQ">RMTI</a>) climbed 19 percent to close at $6.21.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) rose 18.49 percent to close at $5.17.</li>
<li>Sorrento Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srne#NASDAQ">SRNE</a>) gained 18.03 percent to close at $2.75.</li>
<li>Liquid Media Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yvr#NASDAQ">YVR</a>) gained 17.35 percent to close at $3.45.</li>
<li>Translate Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tbio#NASDAQ">TBIO</a>) climbed 16.63 percent to close at $9.61. Translate Bio highlighted publication of preclinical data demonstrating efficacy of systemic mRNA delivery in Fabry disease model in the Journal Molecular Therapy.</li>
<li>Smart Sand, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snd#NASDAQ">SND</a>) rose 16.42 percent to close at $4.67.</li>
<li>DASAN Zhone Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dzsi#NASDAQ">DZSI</a>) rose 15.54 percent to close at $11.81. DASAN Zhone expects Q1 organic revenue of $63 million to $66 million and FY19 organic revenue of $304 million to $310 million.</li>
<li>Viomi Technology Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/viot#NASDAQ">VIOT</a>) climbed 15.13 percent to close at $12.00 after reporting Q4 results.</li>
<li>Innovate Biopharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/innt#NASDAQ">INNT</a>) shares gained 14.94 percent to close at $2.48 after reporting entry into securities purchase agreement to fund initiation of the first Phase 3 celiac disease clinical trial.</li>
<li>Village Farms International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vff#NASDAQ">VFF</a>) gained 14.01 percent to close at $16.33.</li>
<li>Replimune Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/repl#NASDAQ">REPL</a>) climbed 13.57 percent to close at $13.13.</li>
<li>Karyopharm Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kpti#NASDAQ">KPTI</a>) gained 12.95 percent to close at $5.31.</li>
<li>Synthorx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thor#NASDAQ">THOR</a>) gained 12.23 percent to close at $21.51.</li>
<li>Akari Therapeutics, Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aktx#NASDAQ">AKTX</a>) rose 12.01 percent to close at $4.57 after falling 29.66 percent on Friday.</li>
<li>Cellectar Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clrb#NASDAQ">CLRB</a>) climbed 11.97 percent to close at $2.74.</li>
<li>Overseas Shipholding Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/osg#NYSE">OSG</a>) shares rose 11.84 percent to close at $2.55.</li>
<li>Digital Turbine, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apps#NASDAQ">APPS</a>) shares jumped 11.76 percent to close at $3.39 on Monday.</li>
<li>AVROBIO, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avro#NASDAQ">AVRO</a>) gained 11.73 percent to close at $17.63.</li>
<li>360 Finance, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qfin#NASDAQ">QFIN</a>) rose 11.64 percent to close at $16.51.</li>
<li>CHF Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chfs#NASDAQ">CHFS</a>) gained 11 percent to close at $3.92.</li>
<li>Triple-S Management Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gts#NYSE">GTS</a>) rose 10.85 percent to close at $27.28.</li>
<li>China SXT Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sxtc#NASDAQ">SXTC</a>) rose 10.82 percent to close at $6.96.</li>
<li>Worldpay, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wp#NYSE">WP</a>) shares gained 9.96 percent to close at $108.51. Fidelity National Information Services Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fis#NYSE">FIS</a>) agreed to buy Worldpay for around $35 billion.</li>
<li>Oragenics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ogen#NYSE">OGEN</a>) gained 7.6 percent to close at $0.9576 after the company announced it has enrolled the 60th patient in its Phase 2 double-blind for its clinical trial of AG013.</li>
<li>Cue Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cue#NASDAQ">CUE</a>) rose 7.12 percent to close at $8.56.</li>
<li>Avid Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avid#NASDAQ">AVID</a>) shares rose 5.06 percent to close at $6.53.</li>
<li>Deutsche Bank AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) rose 4.3 percent to close at $9.26 after confirming it&#39;s in merger talks with fellow German-based bank Commerzbank.</li>
<li>AzurRx BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/azrx#NASDAQ">AZRX</a>) shares rose 4.2 percent to close at $2.14 after the company announced it will present Phase II MS1819-SD data at the 2019 Digestive Disease Week Conference.</li>
</ul>
&nbsp;
<h3>Losers</h3>
<ul>
<li>Aerpio Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arpo#NASDAQ">ARPO</a>) shares tumbled 70.54 percent to close at $1.22 on Monday after the company announced that its Phase 2 TIME-2b study of AKB-9778 did not meet its primary endpoint.</li>
<li>NII Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nihd#NASDAQ">NIHD</a>) dropped 27.9 percent to close at $2.27. NII Holdings posted Q4 earnings of $0.02 per share on sales of $141.7 million. The company also announced the sale of Nextel Brazil to America Movil.</li>
<li>Synaptics Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syna#NASDAQ">SYNA</a>) shares fell 22.46 percent to close at $33.46 after the company lowered its guidance for the third quarter and reported the departure of CFO Richard Bergman.</li>
<li>FutureFuel Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ff#NYSE">FF</a>) shares fell 20.95 percent to close at $14.11 after the company reported Q4 EPS of $0.04, down from $0.36 last year and Q4 sales of $65.51 million, down from $75.26 million last year.</li>
<li>Globus Maritime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glbs#NASDAQ">GLBS</a>) fell 19.22 percent to close at $4.6100. Globus Maritime reported a Q4 loss of $0.42 per share, on sales of $4.36 million.</li>
<li>Sensus Healthcare, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srts#NASDAQ">SRTS</a>) dropped 16.25 percent to close at $7.90.</li>
<li>BioScrip, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bios#NASDAQ">BIOS</a>) fell 15.47 percent to close at $2.34. Stephens &amp; Co. downgraded BioScrip from Overweight to Equal-Weight.</li>
<li>Polarityte Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pte#NASDAQ">PTE</a>) fell 15.29 percent to close at $13.05 after the company announced it is the subject of an SEC investigation and used $8M of cash during a 2 month transitional period.</li>
<li>Trinity Place Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tphs#NYSE">TPHS</a>) dipped 14.13 percent to close at $4.0100.</li>
<li>vTv Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtvt#NASDAQ">VTVT</a>) fell 13.91 percent to close at $2.0000 after reporting $15 million in Class A common stock financings.</li>
<li>PHI, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phii#NASDAQ">PHII</a>) dipped 12.64 percent to close at $2.49. PHI posted Q4 results on Monday.</li>
<li>GP Strategies Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gpx#NYSE">GPX</a>) shares dropped 12.63 percent to close at $12.52 after reporting downbeat Q4 results.</li>
<li>Qutoutiao Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtt#NASDAQ">QTT</a>) dropped 12.6 percent to close at $13.57.</li>
<li>Adamis Pharmaceuticals Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/admp#NASDAQ">ADMP</a>) fell 12.1 percent to close at $2.3900 after dropping 3.90 percent on Friday.</li>
<li>CohBar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cwbr#NASDAQ">CWBR</a>) dipped 9.74 percent to close at $3.4700.</li>
<li>Ra Medical Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rmed#NYSE">RMED</a>) fell 9.71 percent to close at $4.00.</li>
<li>KalVista Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kalv#NASDAQ">KALV</a>) dropped 9.67 percent to close at $26.33.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adil#NASDAQ">ADIL</a>) fell 9.06 percent to close at $3.01.</li>
<li>Coda Octopus Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coda#NASDAQ">CODA</a>) dropped 7.69 percent to close at $8.55. Coda Octopus reported Q1 earnings of $0.12 per share on sales of $5.76 million.</li>
<li>Huami Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hmi#NYSE">HMI</a>) shares fell 6.36 percent to close at $14.44 after gaining 5.91 percent on Friday.</li>
<li>Turtle Beach Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hear#NASDAQ">HEAR</a>) dipped 6.31 percent to close at $12.46.</li>
<li>Chaparral Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chap#NYSE">CHAP</a>) shares dropped 6.3 percent to close at $4.4600.</li>
<li>Key Energy Services, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/keg#NYSE">KEG</a>) fell 6.02 percent to close at $5.78.</li>
</ul>

Toward the end of trading Monday, the Dow traded up 0.1 percent to 25,875.10 while the NASDAQ climbed 0.23 percent to 7,705.94. The S&amp;P also rose, gaining 0.25 percent to 2,829.48.

Leading and Lagging Sectors
Monday afternoon, the energy shares climbed 1.2 percent. Meanwhile, top gainers in the sector included American Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amid#NYSE">AMID</a>) up 28 percent, and Smart Sand, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snd#NASDAQ">SND</a>) up 11 percent.
In trading on Monday, communication services shares fell 0.8 percent.

Top Headline
Fidelity National Information Servcs Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fis#NYSE">FIS</a>) reached an agreement to buy Worldpay, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wp#NYSE">WP</a>), an e-commerce and payments company for around $34 billion.
The combination of FIS and Worldpay will create a new entity that will offer a best-in-class enterprise banking, payments, capital markets and global e-commerce capabilities, the companies said in a press release. The companies combined for $12.3 billion in pro forma annual revenue in 2018.
&nbsp;
Equities Trading UP
Dar&eacute; Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dare#NASDAQ">DARE</a>) shares got a boost, shooting up 150 percent to $2.2531 following positive results for its vaginally administered tamoxifen. Dare Bioscience said Monday its DARE-VVA1, a proprietary formulation of tamoxifen for vaginal administration being evaluated as a potential treatment option for vulvar and vaginal atrophy (VVA) in patients with hormone-receptor-positive breast cancer, showed significant improvements in reducing vaginal pH and vaginal dryness without significant systemic absorption of tamoxifen.
Shares of Dermira, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/derm#NASDAQ">DERM</a>) shot up 76 percent to $12.02 after an announcement from the company regarding a midstage trial involving its investigational candidate for atopic dermatitis. Dermira reported positive results ahead of the market open Monday from a Phase 2b dose-ranging study of lebrikizumab that is being evaluated for treating adult patients with moderate-to-severe atopic dermatitis.
PhaseBio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phas#NASDAQ">PHAS</a>) shares were also up, gaining 60 percent to $5.96 after the New England Journal of Medicine published the positive Phase 1 results for the company&#39;s PB2452.

Equities Trading DOWN

Aerpio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arpo#NASDAQ">ARPO</a>) shares dropped 71 percent to $1.24 after the company announced that its Phase 2 TIME-2b study of AKB-9778 did not meet its primary endpoint.
Shares of NII Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nihd#NASDAQ">NIHD</a>) were down 27 percent to $2.3350 after the company reported worse-than-expected Q4 sales results. The company also announced the sale of Nextel Brazil to America Movil.
FutureFuel Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ff#NYSE">FF</a>) was down, falling around 22 percent to $13.99 after the company reported Q4 EPS of $0.04, down from $0.36 last year and Q4 sales of $65.51 million, down from $75.26 million last year.

Commodities
In commodity news, oil traded up 1.01 percent to $59.11 while gold traded down 0.1 percent to $1,302.50.

Silver traded up 0.1 percent Monday to $15.335, while copper rose 0.2 percent to $2.9105.
&nbsp;
Eurozone
European shares closed mostly higher today. The eurozone&rsquo;s STOXX 600 gained 0.27 percent, the Spanish Ibex Index rose 0.72 percent, while Italy&rsquo;s FTSE MIB Index rose 0.90 percent. Meanwhile the German DAX declined 0.25 percent, and the French CAC 40 gained 0.14 percent while U.K. shares rose 0.98 percent.
Economics
The National Association of Home Builders&rsquo; housing market index was unchanged at a reading of 62 for March. However, economists were expecting a reading of 63.

Eurozone

Commodities

Global

Intraday Update

Mid-Afternoon Market Update: Crude Oil Up 1%; Dare Bioscience Shares Spike Higher

<h3>Gainers</h3>
<ul>
<li>Dare Bioscience Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dare#NASDAQ">DARE</a>) shares surged 125.8 percent to $2.0317 after the company published positive clinical findings for Tamoxifen for the treatment of vulvar and vaginal atrophy in a medical journal.</li>
<li>Dermira, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/derm#NASDAQ">DERM</a>) shares surged 99.3 percent to $13.63 after the company announced that its Phase 2 study of Lebrikizumab met its primary endpoint.</li>
<li>PhaseBio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phas#NASDAQ">PHAS</a>) jumped 62.6 percent to $6.05 after the New England Journal of Medicine published the positive Phase 1 results for the company&#39;s PB2452.</li>
<li>Atossa Genetics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atos#NASDAQ">ATOS</a>) gained 35.1 percent to $4.7430 after the company reported the receipt of $10 million from exercises of previously outstanding warrants.</li>
<li>American Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amid#NYSE">AMID</a>) rose 28 percent to $5.12 after the company announced that it would be acquired by ArcLight Energy for $5.25 per share.</li>
<li>Aclaris Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acrs#NASDAQ">ACRS</a>) climbed 26.3 percent to $7.11 after the company reported higher-than-expected Q4 sales.</li>
<li>Akari Therapeutics, Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aktx#NASDAQ">AKTX</a>) gained 21 percent to $4.9346 after falling 29.66 percent on Friday.</li>
<li>Innovate Biopharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/innt#NASDAQ">INNT</a>) shares climbed 18.3 percent to $2.5316 after reporting entry into securities purchase agreement to fund initiation of the first Phase 3 celiac disease clinical trial.</li>
<li>DASAN Zhone Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dzsi#NASDAQ">DZSI</a>) gained 14.5 percent to $11.65. DASAN Zhone expects Q1 organic revenue of $63 million to $66 million and FY19 organic revenue of $304 million to $310 million.</li>
<li>Gritstone Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grts#NASDAQ">GRTS</a>) rose 13.9 percent to $11.56.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) gained 12.7 percent to $4.9353.</li>
<li>Xtant Medical Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xtnt#NASDAQ">XTNT</a>) climbed 12.3 percent to $3.2900.</li>
<li>Village Farms International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vff#NASDAQ">VFF</a>) gained 11 percent to $15.87.</li>
<li>Cue Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cue#NASDAQ">CUE</a>) gained 11.1 percent to $8.90.</li>
<li>AzurRx BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/azrx#NASDAQ">AZRX</a>) shares climbed 10.5 percent to $2.2550 after the company announced it will present Phase II MS1819-SD data at the 2019 Digestive Disease Week Conference.</li>
<li>Iconix Brand Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icon#NASDAQ">ICON</a>) rose 10.4 percent to $2.23.</li>
<li>Smart Sand, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snd#NASDAQ">SND</a>) gained 10 percent to $4.39.</li>
<li>Avid Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avid#NASDAQ">AVID</a>) shares climbed 9.4 percent to $6.82.</li>
<li>Worldpay, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wp#NYSE">WP</a>) shares rose 9 percent to $107.54. Fidelity National Information Services Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fis#NYSE">FIS</a>) agreed to buy Worldpay for around $35 billion.</li>
<li>Sientra, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sien#NASDAQ">SIEN</a>) gained 8.2 percent to $9.56.</li>
<li>Leap Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lptx#NASDAQ">LPTX</a>) rose 8.1 percent to $2.4310 after surging 21.62 percent on Friday. Leap Therapeutics announced the presentation of clinical data from its Phase 2 clinical trial of DKN-01 at the Society of Gynecologic Oncology 50th Annual Meeting on Women&#39;s Cancer.</li>
<li>Riot Blockchain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) rose 7.8 percent to $4.02 after gaining 9.71 percent on Friday.</li>
<li>CHF Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chfs#NASDAQ">CHFS</a>) rose 7.6 percent to $3.82.</li>
<li>Oragenics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ogen#NYSE">OGEN</a>) gained 6.8 percent to $0.9499 after the company announced it has enrolled the 60th patient in its Phase 2 double-blind for its clinical trial of AG013.</li>
<li>Deutsche Bank AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/db#NYSE">DB</a>) rose 4 percent to $9.23 after confirming it&#39;s in merger talks with fellow German-based bank Commerzbank.</li>
</ul>
&nbsp;
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Aerpio Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arpo#NASDAQ">ARPO</a>) shares dipped 69.2 percent to $1.31 after the company announced that its Phase 2 TIME-2b study of AKB-9778 did not meet its primary endpoint.</li>
<li>NII Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nihd#NASDAQ">NIHD</a>) fell 29 percent to $2.2650. NII Holdings posted Q4 earnings of $0.02 per share on sales of $141.7 million. The company also announced the sale of Nextel Brazil to America Movil.</li>
<li>FutureFuel Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ff#NYSE">FF</a>) shares declined 21.9 percent to $13.95 after the company reported Q4 EPS of $0.04, down from $0.36 last year and Q4 sales of $65.51 million, down from $75.26 million last year.</li>
<li>Synaptics Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syna#NASDAQ">SYNA</a>) shares fell 19.7 percent to $34.72 after the company lowered its guidance for the third quarter and reported the departure of CFO Richard Bergman.</li>
<li>Sensus Healthcare, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srts#NASDAQ">SRTS</a>) dropped 16.3 percent to $7.73.</li>
<li>Globus Maritime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glbs#NASDAQ">GLBS</a>) fell 14.6 percent to $4.8000. Globus Maritime reported a Q4 loss of $0.42 per share, on sales of $4.36 million.</li>
<li>Key Energy Services, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/keg#NYSE">KEG</a>) dipped 14.4 percent to $5.27.</li>
<li>GP Strategies Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gpx#NYSE">GPX</a>) shares fell 14.2 percent to $12.30 after reporting downbeat Q4 results.</li>
<li>Trinity Place Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tphs#NYSE">TPHS</a>) dropped 13.9 percent to $4.0207.</li>
<li>CohBar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cwbr#NASDAQ">CWBR</a>) dipped 13 percent to $3.3073.</li>
<li>vTv Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtvt#NASDAQ">VTVT</a>) fell 12.6 percent to $2.01 after reporting $15 million in Class A common stock financings.</li>
<li>Lumber Liquidators Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ll#NYSE">LL</a>) fell 11.7 percent to $8.98. Lumber Liquidators posted upbeat Q4 earnings, while sales missed estimates.</li>
<li>Coda Octopus Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coda#NASDAQ">CODA</a>) dropped 11.3 percent to $8.20. Coda Octopus reported Q1 earnings of $0.12 per share on sales of $5.76 million.</li>
<li>Polarityte Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pte#NASDAQ">PTE</a>) fell 10 percent to $13.93 after the company announced it is the subject of an SEC investigation and used $8M of cash during a 2 month transitional period.</li>
<li>Bioceres Crop Solutions Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/biox#NYSE">BIOX</a>) shares dipped 10 percent to $4.41.</li>
<li>Chaparral Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chap#NYSE">CHAP</a>) shares dropped 9.7 percent to $4.30.</li>
<li>BioScrip, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bios#NASDAQ">BIOS</a>) fell 9 percent to $2.53. Stephens &amp; Co. downgraded BioScrip from Overweight to Equal-Weight.</li>
<li>Turtle Beach Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hear#NASDAQ">HEAR</a>) dipped 8.8 percent to $12.15.</li>
<li>Huami Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hmi#NYSE">HMI</a>) shares fell 8 percent to $14.19 after gaining 5.91 percent on Friday.</li>
<li>Adamis Pharmaceuticals Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/admp#NASDAQ">ADMP</a>) fell 7.4 percent to $2.5100 after dropping 3.90 percent on Friday.</li>
<li>XpresSpa Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xspa#NASDAQ">XSPA</a>) shares dipped 7.1 percent to $3.41.</li>
<li>Tenax Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tenx#NASDAQ">TENX</a>) shares fell 6.7 percent to $1.9494 after climbing 28.22 percent on Friday.</li>
<li>Yintech Investment Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/yin#NYSE">YIN</a>) dropped 5.2 percent to $6.45 after the company reported Q4 EPS of $(0.25) down from $0.12 last year and sales of $41.7 million down from $59.3 million last year.</li>
</ul>

BIOX

LPTX

RIOT

SIEN

TENX

XSPA

XTNT

48 Stocks Moving In Monday's Mid-Day Session

Midway through trading Monday, the Dow traded down 0.15 percent to 25,809.65 while the NASDAQ declined 0.06 percent to 7,684.03. The S&amp;P rose 0.04 percent to 2,823.67.

Leading and Lagging Sectors
On Monday, the energy shares climbed 1.1 percent. Meanwhile, top gainers in the sector included American Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amid#NYSE">AMID</a>) up 28 percent, and Smart Sand, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snd#NASDAQ">SND</a>) up 11 percent.
In trading on Monday, communication services shares fell 0.8 percent.

Top Headline
Fidelity National Information Servcs Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fis#NYSE">FIS</a>) reached an agreement to buy Worldpay, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wp#NYSE">WP</a>), an e-commerce and payments company for around $34 billion.
The combination of FIS and Worldpay will create a new entity that will offer a best-in-class enterprise banking, payments, capital markets and global e-commerce capabilities, the companies said in a press release. The companies combined for $12.3 billion in pro forma annual revenue in 2018.
&nbsp;
Equities Trading UP
Dar&eacute; Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dare#NASDAQ">DARE</a>) shares got a boost, shooting up 140 percent to $2.16 after the company published positive clinical findings for Tamoxifen for the treatment of vulvar and vaginal atrophy in a medical journal.
Shares of Dermira, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/derm#NASDAQ">DERM</a>) shot up 92 percent to $13.10 after an announcement from the company regarding a midstage trial involving its investigational candidate for atopic dermatitis. Dermira reported positive results ahead of the market open Monday from a Phase 2b dose-ranging study of lebrikizumab that is being evaluated for treating adult patients with moderate-to-severe atopic dermatitis.
PhaseBio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phas#NASDAQ">PHAS</a>) shares were also up, gaining 54 percent to $5.72 after the New England Journal of Medicine published the positive Phase 1 results for the company&#39;s PB2452.

Equities Trading DOWN

Aerpio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arpo#NASDAQ">ARPO</a>) shares dropped 69 percent to $1.32 after the company announced that its Phase 2 TIME-2b study of AKB-9778 did not meet its primary endpoint.
Shares of NII Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nihd#NASDAQ">NIHD</a>) were down 30 percent to $2.2325 after the company reported worse-than-expected Q4 sales results. The company also announced the sale of Nextel Brazil to America Movil.
FutureFuel Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ff#NYSE">FF</a>) was down, falling around 22 percent to $13.92 after the company reported Q4 EPS of $0.04, down from $0.36 last year and Q4 sales of $65.51 million, down from $75.26 million last year.

Commodities
In commodity news, oil traded up 0.7 percent to $58.94 while gold traded up 0.1 percent to $1,303.40.

Silver traded up 0.1 percent Monday to $15.34, while copper rose 0.1 percent to $2.906.
&nbsp;
Eurozone
European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 gained 0.09 percent, the Spanish Ibex Index rose 0.55 percent, while Italy&rsquo;s FTSE MIB Index rose 0.78 percent. Meanwhile the German DAX declined 0.37 percent, and the French CAC 40 gained 0.01 percent while U.K. shares rose 0.86 percent.
Economics
The National Association of Home Builders&rsquo; housing market index was unchanged at a reading of 62 for March. However, economists were expecting a reading of 63.

Mid-Day Market Update: FutureFuel Falls After Q4 Results; Dermira Shares Jump

Following the market opening Monday, the Dow traded up 0.04 percent to 25,860.01 while the NASDAQ climbed 0.49 percent to 7,726.29. The S&amp;P also rose, gaining 0.36 percent to 2,832.62.

Leading and Lagging Sectors
Monday morning, the energy shares climbed 1 percent. Meanwhile, top gainers in the sector included American Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amid#NYSE">AMID</a>) up 28 percent, and Smart Sand, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snd#NASDAQ">SND</a>) up 9 percent.
In trading on Monday, communication services shares fell 0.5 percent.

Top Headline
Fidelity National Information Servcs Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fis#NYSE">FIS</a>) reached an agreement to buy Worldpay, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wp#NYSE">WP</a>), an e-commerce and payments company for around $34 billion.
The combination of FIS and Worldpay will create a new entity that will offer a best-in-class enterprise banking, payments, capital markets and global e-commerce capabilities, the companies said in a press release. The companies combined for $12.3 billion in pro forma annual revenue in 2018.
&nbsp;
Equities Trading UP
Dar&eacute; Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dare#NASDAQ">DARE</a>) shares got a boost, shooting up 142 percent to $2.17 after the company published positive clinical findings for Tamoxifen for the treatment of vulvar and vaginal atrophy in a medical journal.
Shares of Dermira, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/derm#NASDAQ">DERM</a>) shot up 102 percent to $13.80 after the company announced that its Phase 2 study of Lebrikizumab met its primary endpoint.
PhaseBio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phas#NASDAQ">PHAS</a>) shares were also up, gaining 73 percent to $6.44 after the New England Journal of Medicine published the positive Phase 1 results for the company&#39;s PB2452.

Equities Trading DOWN

Aerpio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arpo#NASDAQ">ARPO</a>) shares dropped 68 percent to $1.36 after the company announced that its Phase 2 TIME-2b study of AKB-9778 did not meet its primary endpoint.
Shares of NII Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nihd#NASDAQ">NIHD</a>) were down 26 percent to $2.37. NII Holdings posted Q4 earnings of $0.02 per share on sales of $141.7 million. The company also announced the sale of Nextel Brazil to America Movil.
Synaptics Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syna#NASDAQ">SYNA</a>) was down, falling around 20 percent to $34.76 after the company lowered Q3 guidance, citing &quot;demand softness in China.&quot;; The company&#39;s CEO Richard Bergman also resigned.

Commodities
In commodity news, oil traded up 0.2 percent to $58.63 while gold traded up 0.2 percent to $1,305.20.

Silver traded up 0.3 percent Monday to $15.37, while copper rose 0.5 percent to $2.9215.
&nbsp;
Eurozone
European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 gained 0.1 percent, the Spanish Ibex Index rose 0.7 percent, while Italy&rsquo;s FTSE MIB Index rose 0.9 percent. Meanwhile the German DAX declined 0.3 percent, and the French CAC 40 gained 0.1 percent while U.K. shares rose 0.6 percent.
Economics
The National Association of Home Builders&rsquo; housing market index was unchanged at a reading of 62 for March. However, economists were expecting a reading of 63.
The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.

Mid-Morning Market Update: Markets Edge Higher; Fidelity National To Buy Worldpay

WIIM

American Midstream Partners LP shares are trading higher after the company announced that it would be acquired by ArcLight Energy for $5.25 per share.

<h3>Gainers</h3>
<ul>
<li>PhaseBio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phas#NASDAQ">PHAS</a>) rose 90.9 percent to $7.10 in pre-market trading after the company disclosed that full Results were published from Phase 1 clinical trial of PB2452 in the New England Journal of Medicine and were presented at the American College of Cardiology&rsquo;s 68th Annual Scientific Session.</li>
<li>Dermira, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/derm#NASDAQ">DERM</a>) shares rose 84.8 percent to $12.64 in pre-market trading after the company disclosed that its Phase 2b study of lebrikizumab in patients with atopic dermatitis met its primary endpoint.</li>
<li>Leap Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lptx#NASDAQ">LPTX</a>) rose 49.3 percent to $3.36 in pre-market trading after surging 21.62 percent on Friday. Leap Therapeutics announced the presentation of clinical data from its Phase 2 clinical trial of DKN-01 at the Society of Gynecologic Oncology 50th Annual Meeting on Women&#39;s Cancer.</li>
<li>American Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amid#NYSE">AMID</a>) rose 29.8 percent to $5.19 in pre-market trading after the company agreed to be acquired by an affiliate of ArcLight Energy Partners Fund V, L.P. for $5.25 per share in cash.</li>
<li>Tenax Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tenx#NASDAQ">TENX</a>) rose 19.2 percent to $2.49 in pre-market trading after climbing 28.22 percent on Friday.</li>
<li>Riot Blockchain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) rose 14 percent to $4.25 in pre-market trading after gaining 9.71 percent on Friday.</li>
<li>CHF Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chfs#NASDAQ">CHFS</a>) rose 12.4 percent to $3.99 in pre-market trading.</li>
<li>DropCar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dcar#NASDAQ">DCAR</a>) rose 10.9 percent to $4.90 in pre-market trading after falling 11.24 percent on Friday.</li>
<li>Akari Therapeutics, Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aktx#NASDAQ">AKTX</a>) rose 10.5 percent to $4.51 in pre-market trading after falling 29.66 percent on Friday.</li>
<li>China Automotive Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/caas#NASDAQ">CAAS</a>) rose 10.3 percent to $4.50 in pre-market trading.</li>
<li>Huami Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hmi#NYSE">HMI</a>) shares rose 10.3 percent to $17.00 in pre-market trading after gaining 5.91 percent on Friday.</li>
<li>Worldpay, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wp#NYSE">WP</a>) shares rose 9.3 percent to $107.80 in pre-market trading. Fidelity National Information Services Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fis#NYSE">FIS</a>) agreed to buy Worldpay for around $35 billion</li>
<li>J.Jill, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jill#NYSE">JILL</a>) shares rose 7.7 percent to $6.46 in pre-market trading.</li>
<li>Neptune Wellness Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nept#NASDAQ">NEPT</a>) rose 7.1 percent to $3.60 in pre-market trading.</li>
<li>Duluth Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dlth#NASDAQ">DLTH</a>) rose 6.4 percent to $ 23.50 in pre-market trading.</li>
</ul>

Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>NII Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nihd#NASDAQ">NIHD</a>) fell 43.6 percent to $1.80 in pre-market trading. NII Holdings posted Q4 earnings of $0.02 per share on sales of $141.7 million. The company also announced the sale of Nextel Brazil to America Movil.</li>
<li>Synaptics Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syna#NASDAQ">SYNA</a>) shares fell 17.8 percent to $35.53 in pre-market trading after the company lowered its guidance for the third quarter and reported the departure of CFO Richard Bergman</li>
<li>BioScrip, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bios#NASDAQ">BIOS</a>) fell 16.2 percent to $2.33 in pre-market trading. Stephens &amp; Co. downgraded BioScrip from Overweight to Equal-Weight.</li>
<li>Globus Maritime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glbs#NASDAQ">GLBS</a>) fell 15.5 percent to $4.75 in pre-market trading. Globus Maritime reported a Q4 loss of $0.42 per share, on sales of $4.36 million.</li>
<li>Soleno Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slno#NASDAQ">SLNO</a>) fell 14.9 percent to $2.28 in pre-market trading after surging 98.52 percent on Friday.</li>
<li>Achieve Life Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/achv#NASDAQ">ACHV</a>) shares fell 6.3 percent to $2.82 in pre-market trading after rising 22.86 percent on Friday.</li>
<li>Adamis Pharmaceuticals Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/admp#NASDAQ">ADMP</a>) fell 5.9 percent to $2.55 in pre-market trading after dropping 3.90 percent on Friday.</li>
<li>Lumber Liquidators Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ll#NYSE">LL</a>) fell 4.2 percent to $9.75 in pre-market trading. Lumber Liquidators posted upbeat Q4 earnings, while sales missed estimates.</li>
<li>The Boeing Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ba#NYSE">BA</a>) fell 2.9 percent to $ 368.00 in pre-market trading.</li>
</ul>

ACHV

CAAS

DCAR

DLTH

JILL

NEPT

SLNO

24 Stocks Moving In Monday's Pre-Market Session

Pre-open movers
U.S. stock futures traded mixed in early pre-market trade. The National Association of Home Builders&#39; housing market index for March is schedule for release at 10:00 a.m. ET.
Futures for the Dow Jones Industrial Average dropped 68 points to 25,831, while the Standard &amp; Poor&rsquo;s 500 index futures gained 0.70 points to 2,830.50. Futures for the Nasdaq 100 index rose 4.25 points to 7,347.50.
<a href="https://www.benzinga.com/investing/global-oil-storage-trends/">Oil prices </a> traded mixed as Brent crude futures rose 0.04 percent to trade at $67.19 per barrel, while US WTI crude futures fell 0.15 percent to trade at $58.43 a barrel.
A Peek Into Global Markets
European markets were higher today, with the Spanish Ibex Index rising 0.6 percent, STOXX Europe 600 Index climbing 0.2 percent and German DAX 30 index dropped 0.1 percent. The UK&#39;s FTSE index was trading higher by 0.6 percent, while French CAC 40 Index gained 0.1 percent.
In Asian markets, Japan&rsquo;s Nikkei Stock Average rose 0.62 percent, Hong Kong&rsquo;s Hang Seng Index climbed 1.37 percent, China&rsquo;s Shanghai Composite Index rose 2.47 percent and India&rsquo;s BSE Sensex rose 0.19 percent.
Broker Recommendation
Analysts at William Blair downgraded Restoration Robotics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hair#NASDAQ">HAIR</a>) from Outperform to Market Perform.
Restoration Robotics shares rose 1.7 percent to $0.92 in pre-market trading.
Breaking News 
<ul>
<li>American Midstream Partners LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amid#NYSE">AMID</a>) agreed to be acquired by an affiliate of ArcLight Energy Partners Fund V, L.P. for $5.25 per share in cash.</li>
<li>Dermira Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/derm#NASDAQ">DERM</a>) disclosed that its Phase 2b study of lebrikizumab in patients with atopic dermatitis met its primary endpoint.</li>
<li>Synaptics, Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syna#NASDAQ">SYNA</a>) lowered its guidance for the third quarter and reported the departure of CFO Richard Bergman.</li>
<li>Consolidated Water Co. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cwco#NASDAQ">CWCO</a>) reported downbeat results for its fourth quarter.</li>
</ul>

Futures

CWCO

SPDR Dow Jones Industrial Average ETF Trust

HAIR

A Peek Into The Markets: US Stock Futures Mixed Ahead Of Housing Market Index

American Midstream to be Acquired for $5.25/Share Cash

<h3>Gainers</h3>
<ul>
<li>Phunware Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) rose 17.3 percent to $58.88 in pre-market trading after dropping 47.37 percent on Thursday.</li>
<li>SAExploration Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/saex#NASDAQ">SAEX</a>) shares rose 15.7 percent to $4.50 in pre-market trading after gaining 2.37 percent on Thursday.</li>
<li>Cerecor Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cerc#NASDAQ">CERC</a>) rose 14.2 percent to $5.14 in pre-market trading after the company disclosed that it has received US patent for CERC-301.</li>
<li>Talend S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlnd#NASDAQ">TLND</a>) rose 13.7 percent to $42.45 in pre-market trading after reporting a narrower-than-expected Q4 loss.</li>
<li>AcelRx Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acrx#NASDAQ">ACRX</a>) rose 8 percent to $2.84 in pre-market trading after gaining 2.73 percent on Thursday.</li>
<li>SS&amp;C Technologies Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssnc#NASDAQ">SSNC</a>) shares rose 7.8 percent to $60.73 in pre-market trading after the company reported upbeat Q4 results.</li>
<li>Caesars Entertainment Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/czr#NASDAQ">CZR</a>) rose 7.3 percent to $ 10.09 in pre-market trading after Carl Icahn is urging Caesars to consider selling itself, The Wall Street Journal reported.</li>
<li>Arista Networks, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/anet#NYSE">ANET</a>) rose 6.7 percent to $257.00 in pre-market trading after reporting stronger-than-expected results for its fourth quarter.</li>
<li>NVIDIA Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) rose 6.1 percent to $163.97 in pre-market trading after the company reported upbeat earnings for its fourth quarter and issued strong sales forecast for its current fiscal year.</li>
<li>Motif Bio plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtfb#NASDAQ">MTFB</a>) rose 6.1 percent to $2.98 in pre-market trading after declining 72.89 percent on Thursday.</li>
<li>Exelixis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exel#NASDAQ">EXEL</a>) rose 5.4 percent to $23.51 in pre-market trading.</li>
<li>Globant S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/glob#NYSE">GLOB</a>) rose 5.1 percent to $71.75 in pre-market trading following upbeat Q4 results.</li>
<li>Innovative Industrial Properties, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iipr#NYSE">IIPR</a>) shares rose 5 percent to $63.50 in pre-market trading. Innovative Industrial Properties will replace Amedisys in the S&amp;P SmallCap 600 on Thursday, February 21.</li>
<li>Redfin Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdfn#NASDAQ">RDFN</a>) rose 5 percent to $19.25 in pre-market trading after reporting a fourth-quarter earnings beat.</li>
<li>Arch Capital Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acgl#NASDAQ">ACGL</a>) shares rose 4.7 percent to $32.58 in pre-market trading.</li>
<li>Vanda Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnda#NASDAQ">VNDA</a>) rose 4.4 percent to $21.00 in pre-market trading after surging 9.23 percent on Thursday.</li>
<li>Suncor Energy Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/su#NYSE">SU</a>) rose 3.5 percent to $33.70 in pre-market trading after Warren Buffett&#39;s Berkshire Hathaway took a position in the stock.</li>
</ul>

Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Marin Software Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrin#NASDAQ">MRIN</a>) shares fell 30.3 percent to $4.60 in pre-market trading after reporting fourth-quarter earnings of $(0.06), up from $(0.92) year-over-year. Sales came in at $15.825 million, down from $17.692 million year-over-year.</li>
<li>TrueCar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/true#NASDAQ">TRUE</a>) fell 19.5 percent to $8.24 in pre-market trading after the company missed Q4 earnings estimates and issued weak Q1 guidance.</li>
<li>LogMeIn, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/logm#NASDAQ">LOGM</a>) fell 17.7 percent to $79.00 in pre-market trading after the company issued Q1 and FY19 guidance well below consensus estimates, offsetting a Q4 earnings beat.</li>
<li>Arcimoto, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fuv#NASDAQ">FUV</a>) fell 14.4 percent to $6.08 in pre-market trading after climbing 108.82 percent on Thursday.</li>
<li>XPO Logistics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpo#NYSE">XPO</a>) fell 14.4 percent to $50.95 in pre-market trading after the company missed Q4 EPS and sales estimates.</li>
<li>Newell Brands Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nwl#NYSE">NWL</a>) fell 13.6 percent to $18.74 in pre-market trading after the company reported downbeat Q4 sales and issued weak sales outlook.</li>
<li>Electrameccanica Vehicles Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/solo#NASDAQ">SOLO</a>) fell 11.6 percent to $4.25 in pre-market trading after surging 11.09 percent on Thursday.</li>
<li>Reed&#39;s, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/reed#NYSE">REED</a>) fell 9.9 percent to $2.20 in pre-market trading after reporting a proposed offering of common stock.</li>
<li>Vedanta Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vedl#NYSE">VEDL</a>) shares fell 7.2 percent to $8.00 in pre-market.</li>
<li>American Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amid#NYSE">AMID</a>) fell 5.1 percent to $3.91 in pre-market trading.</li>
<li>Arcadia Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rkda#NASDAQ">RKDA</a>) fell 4.6 percent to $5.01 in pre-market trading after gaining 4.79 percent on Thursday.</li>
<li>Dr. Reddy&#39;s Laboratories Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rdy#NYSE">RDY</a>) fell 4.2 percent to $36.14 in pre-market trading.</li>
<li>Gold Fields Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gfi#NYSE">GFI</a>) fell 4.2 percent to $3.68 in pre-market trading.</li>
<li>DRDGOLD Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/drd#NYSE">DRD</a>) fell 3.7 percent to $2.08 in pre-market trading.</li>
</ul>

ACGL

ACRX

ANET

CERC

EXEL

GLOB

IIPR

LOGM

MRIN

MTFB

NVDA

PHUN

RDFN

REED

RKDA

SAEX

SOLO

SSNC

TLND

TRUE

VEDL

VNDA

31 Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Voyager Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vygr#NASDAQ">VYGR</a>) shares jumped 38.31 percent to close at $11.12 on Tuesday after the company announced a collaboration with Neurocrine Biosciences. The company received an upfront payment of $165 million and can receive up to $1.7 billion in milestones.</li>
<li>Zynerba Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zyne#NASDAQ">ZYNE</a>) shares gained 25.26 percent to close at $4.81.</li>
<li>Coffee Holding Co., Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jva#NASDAQ">JVA</a>) shares gained 20.58 percent to close at $5.86.</li>
<li>Avadel Pharmaceuticals plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avdl#NASDAQ">AVDL</a>) climbed 19.47 percent to close at $2.70.</li>
<li>Sanmina Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sanm#NASDAQ">SANM</a>) rose 16.88 percent to close at $31.85 after the company reported better-than-expected earnings for its fourth quarter and issued strong second-quarter guidance. Sanmina also reported that CFO David Anderson will retire and the company has begun search for a permanent replacement.</li>
<li>PG&amp;E Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pcg#NYSE">PCG</a>) surged 16.49 percent to close at $13.99. PG&amp;E reported Chapter 11 filing.</li>
<li>Woodward, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wwd#NASDAQ">WWD</a>) rose 12.34 percent to close at $86.78 following upbeat Q1 earnings.</li>
<li>Champions Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/csbr#NASDAQ">CSBR</a>) gained 12.25 percent to close at $10.72.</li>
<li>J &amp; J Snack Foods Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jjsf#NASDAQ">JJSF</a>) climbed 12.01 percent to close at $156.82 after reporting Q1 results.</li>
<li>Digital Ally, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dgly#NASDAQ">DGLY</a>) shares gained 11.8 percent to close at $3.79.</li>
<li>Xerox Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xrx#NYSE">XRX</a>) rose 11.4 percent to close at $27.07 after reporting upbeat Q4 earnings.</li>
<li>Corning Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/glw#NYSE">GLW</a>) gained 11.07 percent to close at $33.72 after the company reported better than expected Q4 EPS and revenue results.</li>
<li>Check-Cap Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chek#NASDAQ">CHEK</a>) rose 10.8 percent to close at $3.90.</li>
<li>iClick Interactive Asia Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iclk#NASDAQ">ICLK</a>) gained 10.74 percent to close at $5.57.</li>
<li>HyreCar Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hyre#NASDAQ">HYRE</a>) climbed 10.7 percent to close at $4.45.</li>
<li>Opera Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opra#NASDAQ">OPRA</a>) rose 10.07 percent to close at $8.09.</li>
<li>Jounce Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jnce#NASDAQ">JNCE</a>) surged 9.91 percent to close at $3.77 on Tuesday.</li>
<li>Northeast Bancorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbn#NASDAQ">NBN</a>) gained 9.89 percent to close at $19.44 following Q2 earnings.</li>
<li>Meritor, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtor#NYSE">MTOR</a>) shares rose 9.88 percent to close at $20.79 after the company reported upbeat Q1 earnings.</li>
<li>Whirlpool Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/whr#NYSE">WHR</a>) rose 9.67 percent to close at $136.49. Whirlpool reported upbeat earnings for its fourth quarter, while sales missed views. The company issued weak FY19 EPS and sales guidance.</li>
<li>Resonant Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/resn#NASDAQ">RESN</a>) surged 9.09 percent to close at $3.48.</li>
<li>Harris Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrs#NYSE">HRS</a>) climbed 8.78 percent to close at $155.22 after the company beat Q2 earnings estimates and issued strong FY19 guidance.</li>
<li>L3 Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lll#NYSE">LLL</a>) gained 8.44 percent to close at $199.59 following Q4 earnings.</li>
<li>Stratasys Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssys#NASDAQ">SSYS</a>) shares rose 8.03 percent to close at $24.07. PiperJaffray upgraded the company&#39;s stock Stratasys from Neutral to Overweight and raised the price target from $19 to $31.</li>
<li>Bridge Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdge#NASDAQ">BDGE</a>) climbed 7.81 percent to close at $30.63 following Q4 earnings.</li>
<li>Carbon Black, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cblk#NASDAQ">CBLK</a>) rose 7.41 percent to close at $15.36 after Raymond James upgraded the company&#39;s stock from Outperform to Strong Buy.</li>
<li>TransDigm Group Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdg#NYSE">TDG</a>) rose 7.11 percent to close at $375.72 after the company provided preliminary sales guidance of $993 million for the 13-week period ended Dec. 29.</li>
<li>Rockwell Automation, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rok#NYSE">ROK</a>) climbed 6.36 percent to close at $173.63 after the company beat Q1 EPS estimates; Sales were in-line with estimates.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) gained 6.33 percent to close at $12.27 after Piper Jaffray upgraded the company&#39;s stock from Neutral to Overweight and announced a price target of $17 per share.</li>
<li>PPDAI Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ppdf#NYSE">PPDF</a>) shares rose 5.5 percent to close at $3.45.</li>
<li>GrafTech International Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eaf#NYSE">EAF</a>) shares climbed 5.18 percent to close at $12.79.</li>
</ul>
&nbsp;
<h3>Losers</h3>
<ul>
<li>GameStop Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) dipped 27.23 percent to close at $11.28 on Tuesday after the company said it is no longer pursuing sale of the firm due to a &#39;lack of available financing on terms that would be commercially acceptable to a prospective acquiror.&#39;</li>
<li>Research Frontiers Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/refr#NASDAQ">REFR</a>) shares fell 16.67 percent to close at $2.4000.</li>
<li>Cancer Genetics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgix#NASDAQ">CGIX</a>) declined 15.75 percent to close at $0.2599. Cancer Genetics priced its 15.21 million share public offering of common stock at $0.23 per share.</li>
<li>Cool Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/awsm#NASDAQ">AWSM</a>) shares fell 14.14 percent to close at $2.6100.</li>
<li>Kiniksa Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/knsa#NASDAQ">KNSA</a>) declined 13.78 percent to close at $18.58 after the company registered for an 8 million share common stock offering.</li>
<li>Accelerate Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axdx#NASDAQ">AXDX</a>) shares declined 13.3 percent to close at $17.41.</li>
<li>Yangtze River Port and Logistics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yriv#NASDAQ">YRIV</a>) dropped 12.96 percent to close at $2.15.</li>
<li>Denali Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dnli#NASDAQ">DNLI</a>) shares fell 11.93 percent to close at $18.82.</li>
<li>Fuwei Films (Holdings) Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ffhl#NASDAQ">FFHL</a>) dropped 11.11 percent to close at $2.16.</li>
<li>Avalon GloboCare Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avco#NASDAQ">AVCO</a>) shares declined 10.97 percent to close at $6.17.</li>
<li>Biocept, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bioc#NASDAQ">BIOC</a>) dipped 10.9 percent to close at $1.88.</li>
<li>SMTC Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smtx#NASDAQ">SMTX</a>) dropped 10.85 percent to close at $5.26.</li>
<li>SPI Energy Co., Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spi#NYSE">SPI</a>) fell 10.76 percent to close at $1.99.</li>
<li>Gridsum Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gsum#NASDAQ">GSUM</a>) shares dipped 10.73 percent to close at $2.0800.</li>
<li>Brinker International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eat#NYSE">EAT</a>) fell 10.71 percent to close at $42.36. Brinker posted in-line Q2 earnings, while sales exceeded estimates.</li>
<li>Nordic American Offshore Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nao#NYSE">NAO</a>) shares dropped 10.53 percent to close at $3.4000.</li>
<li>Square, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sq#NYSE">SQ</a>) fell 10.05 percent to close at $68.56 after Raymond James downgraded the stock to Underperform.</li>
<li>Lantronix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltrx#NASDAQ">LTRX</a>) dropped 9.78 percent to close at $2.86.</li>
<li>Odyssey Marine Exploration, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omex#NASDAQ">OMEX</a>) shares declined 9.63 percent to close at $4.88.</li>
<li>American Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amid#NYSE">AMID</a>) shares fell 9.56 percent to close at $4.07.</li>
<li>Allergan plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/agn#NYSE">AGN</a>) dipped 8.55 percent to close at $145.12 after the company said it expects Q1 EPS of $3.40 to $3.60 versus the $3.75 analyst estimate. The company also expects revenue below analyst expectations.</li>
<li>Allakos Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allk#NASDAQ">ALLK</a>) shares fell 7.7 percent to close at $39.55 after reporting results from Phase 2 study for xolair-na&iuml;ve chronic spontaneous urticaria patients.</li>
<li>Youngevity International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ygyi#NASDAQ">YGYI</a>) shares fell 7.7 percent to close at $7.12.</li>
<li>Bloom Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/be#NYSE">BE</a>) dropped 7.66 percent to close at $9.88 after a 10 percent+ stakeholder sold 273,576 shares at an average price of $11.54.</li>
<li>Sensus Healthcare, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srts#NASDAQ">SRTS</a>) dipped 6.41 percent to close at $7.59.</li>
<li>Autoliv, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alv#NYSE">ALV</a>) fell 5.79 percent to close at $77.61 after the company posted downbeat quarterly earnings.</li>
<li>Harley-Davidson Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hog#NYSE">HOG</a>) shares fell 5.05 percent to close at $34.76 after reporting downbeat Q4 results.</li>
</ul>

ALLK

AVCO

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AWSM

AXDX

BDGE

BIOC

CBLK

CGIX

CHEK

CSBR

DGLY

DNLI

FFHL

GSUM

HYRE

ICLK

JJSF

JNCE

KNSA

LTRX

MTOR

OMEX

OPRA

PPDF

REFR

RESN

SANM

SMTX

SSYS

VYGR

YGYI

YRIV

ZYNE

58 Biggest Movers From Yesterday

<h3>Gainers</h3>
<ul>
<li>Voyager Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vygr#NASDAQ">VYGR</a>) shares climbed 38.3 percent to $11.12 after the company announced a collaboration with Neurocrine Biosciences. The company received an upfront payment of $165 million and can receive up to $1.7 billion in milestones.</li>
<li>Zynerba Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zyne#NASDAQ">ZYNE</a>) shares climbed 34.4 percent to $5.16.</li>
<li>Kazia Therapeutics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kzia#NASDAQ">KZIA</a>) shares gained 25 percent to $3.75.</li>
<li>Sanmina Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sanm#NASDAQ">SANM</a>) rose 17.8 percent to $32.11 after the company reported better-than-expected earnings for its fourth quarter and issued strong second-quarter guidance. Sanmina also reported that CFO David Anderson will retire and the company has begun search for a permanent replacement.</li>
<li>Woodward, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wwd#NASDAQ">WWD</a>) rose 16.9 percent to $90.14 following upbeat Q1 earnings.</li>
<li>PG&amp;E Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pcg#NYSE">PCG</a>) surged 16 percent to $13.93. PG&amp;E reported Chapter 11 filing.</li>
<li>J &amp; J Snack Foods Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jjsf#NASDAQ">JJSF</a>) rose 14.2 percent to $159.83 after reporting Q1 results.</li>
<li>Coffee Holding Co., Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jva#NASDAQ">JVA</a>) shares gained 13.2 percent to $5.50.</li>
<li>HyreCar Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hyre#NASDAQ">HYRE</a>) climbed 11.7 percent to $4.49.</li>
<li>Stratasys Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ssys#NASDAQ">SSYS</a>) shares rose 11.3 percent to $24.79. PiperJaffray upgraded the company&#39;s stock Stratasys from Neutral to Overweight and raised the price target from $19 to $31.</li>
<li>Northeast Bancorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbn#NASDAQ">NBN</a>) gained 10 percent to $19.45 following Q2 earnings.</li>
<li>Boxlight Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/boxl#NASDAQ">BOXL</a>) shares rose 9.7 percent to $2.94 after reporting technology alliances with Critical Links and Modern Robotics, Inc.</li>
<li>Corning Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/glw#NYSE">GLW</a>) gained 9.5 percent to $33.23 after the company reported better than expected Q4 EPS and revenue results.</li>
<li>GrafTech International Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eaf#NYSE">EAF</a>) shares climbed 9.5 percent to $13.32.</li>
<li>Xerox Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xrx#NYSE">XRX</a>) rose 9.2 percent to $26.54 after reporting upbeat Q4 earnings.</li>
<li>Meritor, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtor#NYSE">MTOR</a>) shares rose 8.9 percent to $20.60 after the company reported upbeat Q1 earnings.</li>
<li>Bridge Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdge#NASDAQ">BDGE</a>) climbed 8.7 percent to $30.87 following Q4 earnings.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) gained 8.6 percent to $12.53 after Piper Jaffray upgraded the company&#39;s stock from Neutral to Overweight and announced a price target of $17 per share.</li>
<li>Carbon Black, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cblk#NASDAQ">CBLK</a>) rose 7.7 percent to $15.41 after Raymond James upgraded the company&#39;s stock from Outperform to Strong Buy.</li>
<li>Acorn International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atv#NYSE">ATV</a>) rose 7.3 percent to $24.43.</li>
<li>Harris Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrs#NYSE">HRS</a>) climbed 7.3 percent to $153.13 after the company beat Q2 earnings estimates and issued strong FY19 guidance.</li>
<li>PPDAI Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ppdf#NYSE">PPDF</a>) shares rose 7.1 percent to $3.50.</li>
<li>L3 Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lll#NYSE">LLL</a>) gained 6.5 percent to $195.95 following Q4 earnings.</li>
<li>TransDigm Group Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdg#NYSE">TDG</a>) rose 6.3 percent to $372.96 after the company provided preliminary sales guidance of $993 million for the 13-week period ended Dec. 29.</li>
<li>Whirlpool Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/whr#NYSE">WHR</a>) rose 6.1 percent to $132.07. Whirlpool reported upbeat earnings for its fourth quarter, while sales missed views. The company issued weak FY19 EPS and sales guidance.</li>
<li>Rockwell Automation, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rok#NYSE">ROK</a>) climbed 5.4 percent to $172.03 after the company beat Q1 EPS estimates; Sales were inline with estimates.</li>
</ul>
&nbsp;
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>GameStop Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) tumbled 27.8 percent to $11.19 after the company said it is no longer pursuing sale of the firm due to a &#39;lack of available financing on terms that would be commercially acceptable to a prospective acquiror.&#39;</li>
<li>Cancer Genetics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgix#NASDAQ">CGIX</a>) dropped 16.1 percent to $0.2589. Cancer Genetics priced its 15.21 million share public offering of common stock at $0.23 per share.</li>
<li>Research Frontiers Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/refr#NASDAQ">REFR</a>) shares fell 14.4 percent to $2.4650.</li>
<li>Nordic American Offshore Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nao#NYSE">NAO</a>) shares dropped 12.1 percent to $3.34.</li>
<li>Brinker International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eat#NYSE">EAT</a>) fell 11.3 percent to $42.06. Brinker posted in-line Q2 earnings, while sales exceeded estimates.</li>
<li>Cool Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/awsm#NASDAQ">AWSM</a>) dipped 10.5 percent to $2.72.</li>
<li>Avalon GloboCare Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avco#NASDAQ">AVCO</a>) shares declined 10.4 percent to $6.21.</li>
<li>American Midstream Partners, LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amid#NYSE">AMID</a>) shares dropped 10.2 percent to $4.04.</li>
<li>Square, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sq#NYSE">SQ</a>) fell 9.9 percent to $68.68 after Raymond James downgraded the stock to Underperform.</li>
<li>Allakos Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allk#NASDAQ">ALLK</a>) shares fell 9.4 percent to $38.81 after reporting results from Phase 2 study for xolair-na&iuml;ve chronic spontaneous urticaria patients.</li>
<li>Accelerate Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axdx#NASDAQ">AXDX</a>) shares declined 9.2 percent to $18.24.</li>
<li>Youngevity International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ygyi#NASDAQ">YGYI</a>) shares fell 8.8 percent to $7.04.</li>
<li>Sensus Healthcare, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srts#NASDAQ">SRTS</a>) dipped 8.6 percent to $7.41.</li>
<li>Bloom Energy Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/be#NYSE">BE</a>) dropped 8.4 percent to $9.80 after a 10 percent+ stakeholder sold 273,576 shares at an average price of $11.54.</li>
<li>Kiniksa Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/knsa#NASDAQ">KNSA</a>) declined 8.3 percent to $19.77 after the company registered for an 8 million share common stock offering.</li>
<li>Harley-Davidson Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hog#NYSE">HOG</a>) shares fell 7.7 percent to $33.79 after reporting downbeat Q4 results.</li>
<li>Allergan plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/agn#NYSE">AGN</a>) dipped 7.4 percent to $146.98 after the company said it expects Q1 EPS of $3.40 to $3.60 versus the $3.75 analyst estimate. The company also expects revenue below analyst expectations.</li>
<li>Rambus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rmbs#NASDAQ">RMBS</a>) fell 6.1 percent to $8.28 despite reporting a fourth-quarter earnings beat.</li>
<li>Autoliv, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alv#NYSE">ALV</a>) fell 5.4 percent to $77.93 after the company posted downbeat quarterly earnings.</li>
<li>Polaris Industries Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pii#NYSE">PII</a>) fell 5 percent to $80.69. Polaris posted upbeat Q4 earnings, while sales missed views. The company issued weak FY19 earnings outlook.</li>
</ul>

BOXL

KZIA

46 Stocks Moving In Tuesday's Mid-Day Session

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Argent Mid Cap ETF

Overview

Argent Mid Cap ETF (NASDAQ:AMID), Quote.Headers.trade-ideas